Literature DB >> 20389278

A reversible, non-invasive method for airway resistance measurements and bronchoalveolar lavage fluid sampling in mice.

Sumanth Polikepahad1, Wade T Barranco, Paul Porter, Bruce Anderson, Farrah Kheradmand, David B Corry.   

Abstract

Airway hyperreactivity (AHR) measurements and bronchoalveolar lavage (BAL) fluid sampling are essential to experimental asthma models, but repeated procedures to obtain such measurements in the same animal are generally not feasible. Here, we demonstrate protocols for obtaining from mice repeated measurements of AHR and bronchoalveolar lavage fluid samples. Mice were challenged intranasally seven times over 14 days with a potent allergen or sham treated. Prior to the initial challenge, and within 24 hours following each intranasal challenge, the same animals were anesthetized, orally intubated and mechanically ventilated. AHR, assessed by comparing dose response curves of respiratory system resistance (RRS) induced by increasing intravenous doses of acetylcholine (Ach) chloride between sham and allergen-challenged animals, were determined. Afterwards, and via the same intubation, the left lung was lavaged so that differential enumeration of airway cells could be performed. These studies reveal that repeated measurements of AHR and BAL fluid collection are possible from the same animals and that maximal airway hyperresponsiveness and airway eosinophilia are achieved within 7-10 days of initiating allergen challenge. This novel technique significantly reduces the number of mice required for longitudinal experimentation and is applicable to diverse rodent species, disease models and airway physiology instruments.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20389278      PMCID: PMC3164076          DOI: 10.3791/1720

Source DB:  PubMed          Journal:  J Vis Exp        ISSN: 1940-087X            Impact factor:   1.355


  8 in total

1.  A reevaluation of the validity of unrestrained plethysmography in mice.

Authors:  Lennart K A Lundblad; Charles G Irvin; Andy Adler; Jason H T Bates
Journal:  J Appl Physiol (1985)       Date:  2002-10

2.  Mechanics of respiration in unanesthetized guinea pigs.

Authors:  M O AMDUR; J MEAD
Journal:  Am J Physiol       Date:  1958-02

3.  The use and misuse of Penh in animal models of lung disease.

Authors:  Jason Bates; Charles Irvin; Vito Brusasco; Jeffrey Drazen; Jeffrey Fredberg; Stephen Loring; David Eidelman; Mara Ludwig; Peter Macklem; James Martin; J Milic-Emili; Zoltan Hantos; Robert Hyatt; Stephen Lai-Fook; Alan Leff; Julian Solway; Kenneth Lutchen; Bela Suki; Wayne Mitzner; Peter Paré; Neil Pride; Peter Sly
Journal:  Am J Respir Cell Mol Biol       Date:  2004-09       Impact factor: 6.914

4.  Noninvasive measurement of airway responsiveness in allergic mice using barometric plethysmography.

Authors:  E Hamelmann; J Schwarze; K Takeda; A Oshiba; G L Larsen; C G Irvin; E W Gelfand
Journal:  Am J Respir Crit Care Med       Date:  1997-09       Impact factor: 21.405

5.  Requirement for IL-13 independently of IL-4 in experimental asthma.

Authors:  G Grünig; M Warnock; A E Wakil; R Venkayya; F Brombacher; D M Rennick; D Sheppard; M Mohrs; D D Donaldson; R M Locksley; D B Corry
Journal:  Science       Date:  1998-12-18       Impact factor: 47.728

6.  Requirements for allergen-induced airway hyperreactivity in T and B cell-deficient mice.

Authors:  D B Corry; G Grünig; H Hadeiba; V P Kurup; M L Warnock; D Sheppard; D M Rennick; R M Locksley
Journal:  Mol Med       Date:  1998-05       Impact factor: 6.354

7.  Unrestrained plethysmography is an unreliable measure of airway responsiveness in BALB/c and C57BL/6 mice.

Authors:  Andy Adler; Greg Cieslewicz; Charles G Irvin
Journal:  J Appl Physiol (1985)       Date:  2004-03-19

8.  Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.

Authors:  D B Corry; H G Folkesson; M L Warnock; D J Erle; M A Matthay; J P Wiener-Kronish; R M Locksley
Journal:  J Exp Med       Date:  1996-01-01       Impact factor: 14.307

  8 in total
  6 in total

1.  Necessary and sufficient role for T helper cells to prevent fungal dissemination in allergic lung disease.

Authors:  Paul C Porter; Luz Roberts; Anna Fields; Morgan Knight; Yuping Qian; George L Delclos; Shuhua Han; Farrah Kheradmand; David B Corry
Journal:  Infect Immun       Date:  2011-08-29       Impact factor: 3.441

2.  Ascaris Larval Infection and Lung Invasion Directly Induce Severe Allergic Airway Disease in Mice.

Authors:  Jill E Weatherhead; Paul Porter; Amy Coffey; Dana Haydel; Leroy Versteeg; Bin Zhan; Ana Clara Gazzinelli Guimarães; Ricardo Fujiwara; Ana M Jaramillo; Maria Elena Bottazzi; Peter J Hotez; David B Corry; Coreen M Beaumier
Journal:  Infect Immun       Date:  2018-11-20       Impact factor: 3.441

3.  Blocking KV1.3 channels inhibits Th2 lymphocyte function and treats a rat model of asthma.

Authors:  Shyny Koshy; Redwan Huq; Mark R Tanner; Mustafa A Atik; Paul C Porter; Fatima S Khan; Michael W Pennington; Nicola A Hanania; David B Corry; Christine Beeton
Journal:  J Biol Chem       Date:  2014-03-18       Impact factor: 5.157

4.  Novel acute hypersensitivity pneumonitis model induced by airway mycosis and high dose lipopolysaccharide.

Authors:  Yuying Zeng; Yun Zhang; Xinyan Huang; Lizhen Song; Katherine Polsky; Yifan Wu; Farrah Kheradmand; Yubiao Guo; Linda K Green; David B Corry; John M Knight
Journal:  Respir Res       Date:  2021-10-10

5.  Assessment of murine lung mechanics outcome measures: alignment with those made in asthmatics.

Authors:  Julia K L Walker; Monica Kraft; John T Fisher
Journal:  Front Physiol       Date:  2013-02-12       Impact factor: 4.566

6.  Long-Acting Beta Agonists Enhance Allergic Airway Disease.

Authors:  John M Knight; Garbo Mak; Joanne Shaw; Paul Porter; Catherine McDermott; Luz Roberts; Ran You; Xiaoyi Yuan; Valentine O Millien; Yuping Qian; Li-Zhen Song; Vincent Frazier; Choel Kim; Jeong Joo Kim; Richard A Bond; Joshua D Milner; Yuan Zhang; Pijus K Mandal; Amber Luong; Farrah Kheradmand; John S McMurray; David B Corry
Journal:  PLoS One       Date:  2015-11-25       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.